AU2002368326A1 - Hormone replacement therapy with drospirenone - Google Patents

Hormone replacement therapy with drospirenone

Info

Publication number
AU2002368326A1
AU2002368326A1 AU2002368326A AU2002368326A AU2002368326A1 AU 2002368326 A1 AU2002368326 A1 AU 2002368326A1 AU 2002368326 A AU2002368326 A AU 2002368326A AU 2002368326 A AU2002368326 A AU 2002368326A AU 2002368326 A1 AU2002368326 A1 AU 2002368326A1
Authority
AU
Australia
Prior art keywords
drospirenone
replacement therapy
hormone replacement
hormone
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368326A
Inventor
Siegfried Meyerhofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2002368326A1 publication Critical patent/AU2002368326A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
AU2002368326A 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone Abandoned AU2002368326A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/004628 WO2004041288A1 (en) 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone

Publications (1)

Publication Number Publication Date
AU2002368326A1 true AU2002368326A1 (en) 2004-06-07

Family

ID=32310068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368326A Abandoned AU2002368326A1 (en) 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone

Country Status (2)

Country Link
AU (1) AU2002368326A1 (en)
WO (1) WO2004041288A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005056527A1 (en) * 2005-11-25 2007-07-12 Grünenthal GmbH Use of a combination of ethinylestradiol and chlormadinone acetate for the manufacture of a medicament
EA026095B1 (en) 2010-04-15 2017-03-31 Байер Интеллекчуал Проперти Гмбх Very low-dosed solid oral dosage forms for hormone replacement therapy (hrt)
DE102011012712A1 (en) * 2011-03-01 2012-09-06 Frank Lehmann-Horn Use of aldosterone receptor antagonists for the treatment of female sexual dysfunction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083528A (en) * 1995-09-28 2000-07-04 Schering Aktiengesellschaft Hormone replacement therapy method and hormone dispenser
UA74141C2 (en) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Oral pharmaceutical compositions comprising micronized eplerenone (variants), method for its production and method for treating aldosterone-mediated states (variants)
JP2002533411A (en) * 1998-12-23 2002-10-08 ジー．ディー．サール エルエルシー Combinations for applying to cardiovascular
PL201878B1 (en) * 2000-01-18 2009-05-29 Bayer Schering Pharma Ag Drospirenone for hormone replacement therapy
AU2001280804A1 (en) * 2000-07-27 2002-02-13 Eileen R. Blasi Aldosterone blocker therapy to prevent or treat inflammation-related disorders
AU2001285318A1 (en) * 2000-08-28 2002-03-13 Pharmacia Corporation Use of an aldosterone receptor antagonist to improve cognitive function
DE10100911A1 (en) * 2001-01-11 2002-08-01 Schering Ag Process for hormone replacement therapy and its dosage form

Also Published As

Publication number Publication date
WO2004041288A1 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
AU2003288586A1 (en) Electrode arrangement
AU2003288959A1 (en) Body region indication
AU2003281505A1 (en) Chair
AU2003260760A1 (en) Implantable replacement joint
EP1578782A3 (en) Combination therapy with co-stimulatory factors
AU2003215209A1 (en) Syringe
AU2003296895A1 (en) Combination therapy for controlling appetites
ZA200308027B (en) Hormone replacement therapy
AU2003234929A1 (en) Therapeutic agent for diabetes
AU2003209226A1 (en) Adiponectin gene therapy
AU2003220410A1 (en) Airway assembly
AU2003203099A1 (en) Manually-propelled wheelchair
AU2002313298A1 (en) Body reinforcing material arrangement structure
AU2003259457A1 (en) Auto-destructible syringe
AU2003247005A1 (en) Therapy combination
AU2003293253A1 (en) Selecting electrotherapy dosage
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003228198A1 (en) Av-fistula bandage
AU2003206730A1 (en) Fitting
AU2003215150A1 (en) Therapeutic compounds
AU2003297657A1 (en) Antifungal therapeutic agents
AU2003257843A1 (en) Wheelchair
AU2002368326A1 (en) Hormone replacement therapy with drospirenone
AU2003213956A1 (en) Improved hormone replacement therapy
AU2003255727A1 (en) Syringes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase